Pages that link to "Q34041808"
The following pages link to Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13. (Q34041808):
Displaying 11 items.
- HIF targets in bone remodeling and metastatic disease (Q35554344) (← links)
- High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells. (Q36162776) (← links)
- Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort (Q38791807) (← links)
- Risk factors for bone metastasis in completely resected non-small-cell lung cancer (Q38793159) (← links)
- Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases (Q38843604) (← links)
- Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer (Q40768560) (← links)
- Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer (Q43555541) (← links)
- Prognostic effects of osteoclast inhibitors in extensive stage small cell lung cancer patients with bone metastases (Q57788518) (← links)
- Incidence and Risk Factors for Bone Metastasis in Non-Small Cell Lung Cancer (Q64235632) (← links)
- Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017 (Q93048111) (← links)
- Tumor dormancy in bone (Q97426733) (← links)